Suppr超能文献

加拿大艾伯塔省心脏植入式电子设备植入术后预防性抗生素的使用比率及其对手术部位感染的影响。

Rates of post procedural prophylactic antibiotic use following cardiac implantable electronic device insertion and the impact on surgical site infections in Alberta, Canada.

作者信息

Rennert-May Elissa, Leal Jenine, Zhang Zuying, Rajakumar Irina, Smith Stephanie, Conly John M, Exner Derek, Kuriachan Vikas, Chew Derek

机构信息

Department of Medicine, University of Calgary, Calgary, AB, Canada.

Department of Community Health Sciences, University of Calgary, Calgary, AB, Canada.

出版信息

Antimicrob Resist Infect Control. 2024 Dec 18;13(1):147. doi: 10.1186/s13756-024-01512-3.

Abstract

BACKGROUND

The necessity of post procedural prophylactic antibiotics following clean surgeries is controversial. While most evidence suggests that there is no benefit from these additional antibiotics and guidelines do not support their use, there is a paucity of evidence as to how often they are still being used and their impact on infection outcomes. The current study assessed the use of prophylactic antibiotics following cardiac implantable electronic device (CIED) implantations in the province of Alberta, and their impact on infection and mortality.

METHODS

We conducted a population-based cohort study in the province of Alberta. Administrative data was used to link all patients ≥ 18 who underwent outpatient CIED implantation from January 1, 2011 through December 31, 2019 to antibiotics commonly used for surgical prophylaxis which were prescribed within 48 h of implantation. The primary outcome, explored with an adjusted Poisson model, was incidence of complex surgical site infection within one year of device implantation. All-cause mortality was a secondary outcome.

RESULTS

Post implantation prophylactic antibiotics were used 41% of the time overall, though the rate has been decreasing over time. The most commonly used prophylactic antibiotic was cefalexin (52%). When adjusted analyses were completed, there was no difference in the outcome of infection between those who did and did not receive post implantation prophylactic antibiotics (Relative Risk 0.74, 95% CI 0.46-1.17) and there was no difference in mortality (Relative Risk 0.8, 95% CI 0.63-1.02).

CONCLUSIONS

The use of prophylactic antibiotics following CIED implantation does not correlate to a reduced rate of complex surgical site infection or reduced mortality. The widespread use of these antibiotics, which is not guideline concordant, suggests the need for targeted antimicrobial stewardship interventions for surgical prophylaxis to ensure that antibiotic use is being optimized. Further work should explore other adverse outcomes associated with this antibiotic usage and stewardship programs should explore interventions to educate and reduce antibiotic use for this indication.

摘要

背景

清洁手术后进行术后预防性抗生素治疗的必要性存在争议。虽然大多数证据表明这些额外的抗生素并无益处,且指南也不支持使用,但关于它们的使用频率及其对感染结局的影响,证据却很少。本研究评估了艾伯塔省心脏植入式电子设备(CIED)植入术后预防性抗生素的使用情况及其对感染和死亡率的影响。

方法

我们在艾伯塔省进行了一项基于人群的队列研究。利用行政数据将2011年1月1日至2019年12月31日期间接受门诊CIED植入的所有年龄≥18岁的患者与植入后48小时内开具的常用于手术预防的抗生素进行关联。采用校正泊松模型探究的主要结局是设备植入后一年内复杂手术部位感染的发生率。全因死亡率是次要结局。

结果

总体而言,植入后预防性抗生素的使用时间占41%,不过该比例随时间呈下降趋势。最常用的预防性抗生素是头孢氨苄(52%)。完成校正分析后,接受和未接受植入后预防性抗生素的患者在感染结局方面没有差异(相对风险0.74,95%置信区间0.46 - 1.17),在死亡率方面也没有差异(相对风险0.8,95%置信区间0.63 - 1.02)。

结论

CIED植入后预防性抗生素的使用与复杂手术部位感染率降低或死亡率降低无关。这些抗生素的广泛使用与指南不一致,这表明需要针对手术预防进行有针对性的抗菌管理干预,以确保抗生素的使用得到优化。进一步的工作应探索与这种抗生素使用相关的其他不良结局,管理项目应探索开展教育及减少该适应症抗生素使用的干预措施。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9402/11656946/080cf819c998/13756_2024_1512_Figa_HTML.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验